{"entity":{"type":"insider","cik":"0001607643","url":"/insider/0001607643","json_url":"/insider/0001607643.json","name":"Gardiner Nathaniel S.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":4,"first":"2015-02-17","last":"2023-12-06","span_basis":"filed_date"},"name_variants":[{"name":"Gardiner Nathaniel S.","source":"filing","n_filings":4,"first_seen":"2015-02-17","last_seen":"2023-12-06"}],"transactions":[{"id":8402505,"accession":"0001062993-23-022053","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-23-022053","line_url":"/filing/0001062993-23-022053#line-1","is_derivative":false,"issuer_cik":"0001177648","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001177648","owner_cik":"0001607643","owner_name":"Gardiner Nathaniel S.","owner_url":"/insider/0001607643","role":"Officer (Sr. VP & General Counsel)","officer_title":"Sr. VP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2412.0,"shares_display":"2,412","price_per_share":9.63,"price_display":"9.63","price_state":"stated","total_value":23227.56,"total_display":"23,227.56","shares_owned_after":68154.0,"shares_owned_after_display":"68,154","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-05","filed_date":"2023-12-06","scope":"insider"},{"id":8386662,"accession":"0001177648-19-000013","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001177648-19-000013","line_url":"/filing/0001177648-19-000013#line-4","is_derivative":false,"issuer_cik":"0001177648","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001177648","owner_cik":"0001607643","owner_name":"Gardiner Nathaniel S.","owner_url":"/insider/0001607643","role":"Officer (Sr. VP & General Counsel)","officer_title":"Sr. VP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3270.0,"shares_display":"3,270","price_per_share":95.279,"price_display":"95.28","price_state":"stated","total_value":311562.33,"total_display":"311,562.33","shares_owned_after":23978.0,"shares_owned_after_display":"23,978","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-13","filed_date":"2019-02-13","scope":"insider"},{"id":2268910,"accession":"0000908662-16-000526","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000908662-16-000526","line_url":"/filing/0000908662-16-000526#line-1","is_derivative":false,"issuer_cik":"0001177648","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001177648","owner_cik":"0001607643","owner_name":"Gardiner Nathaniel S.","owner_url":"/insider/0001607643","role":"Officer (Sr. VP & General Counsel)","officer_title":"Sr. VP & General Counsel","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":24.445,"price_display":"24.44","price_state":"stated","total_value":12222.5,"total_display":"12,222.50","shares_owned_after":1900.0,"shares_owned_after_display":"1,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-11","filed_date":"2016-05-12","scope":"insider"},{"id":8392262,"accession":"0000908662-15-000054","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000908662-15-000054","line_url":"/filing/0000908662-15-000054#line-3","is_derivative":false,"issuer_cik":"0001177648","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001177648","owner_cik":"0001607643","owner_name":"Gardiner Nathaniel S.","owner_url":"/insider/0001607643","role":"Officer (Sr. VP & General Counsel)","officer_title":"Sr. VP & General Counsel","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":600.0,"shares_display":"600","price_per_share":33.47,"price_display":"33.47","price_state":"stated","total_value":20082.0,"total_display":"20,082.00","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-17","filed_date":"2015-02-17","scope":"insider"},{"id":8392258,"accession":"0000908662-15-000054","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000908662-15-000054","line_url":"/filing/0000908662-15-000054#line-2","is_derivative":false,"issuer_cik":"0001177648","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001177648","owner_cik":"0001607643","owner_name":"Gardiner Nathaniel S.","owner_url":"/insider/0001607643","role":"Officer (Sr. VP & General Counsel)","officer_title":"Sr. VP & General Counsel","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400.0,"shares_display":"400","price_per_share":33.1,"price_display":"33.10","price_state":"stated","total_value":13240.0,"total_display":"13,240.00","shares_owned_after":1400.0,"shares_owned_after_display":"1,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-17","filed_date":"2015-02-17","scope":"insider"},{"id":8392255,"accession":"0000908662-15-000054","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000908662-15-000054","line_url":"/filing/0000908662-15-000054#line-1","is_derivative":false,"issuer_cik":"0001177648","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001177648","owner_cik":"0001607643","owner_name":"Gardiner Nathaniel S.","owner_url":"/insider/0001607643","role":"Officer (Sr. VP & General Counsel)","officer_title":"Sr. VP & General Counsel","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400.0,"shares_display":"400","price_per_share":33.0,"price_display":"33.00","price_state":"stated","total_value":13200.0,"total_display":"13,200.00","shares_owned_after":400.0,"shares_owned_after_display":"400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-13","filed_date":"2015-02-17","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":2,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001177648","name":"ENANTA PHARMACEUTICALS INC","url":"/issuer/0001177648","role":"Officer (Sr. VP & General Counsel)","n_filings":4,"first_seen":"2015-02-17","last_seen":"2023-12-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001607643","retrieved_at":"2026-08-22T00:39:28+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}